SB 957

  • Virginia Senate Bill
  • 2023 Regular Session
  • Introduced in Senate Jan 06, 2023
  • Passed Senate Feb 03, 2023
  • House
  • Governor

Prescription Drug Affordability Board and Fund; established, drug cost affordability review, etc.

Abstract

Bill Sponsors (1)

Votes


Actions


Feb 22, 2023

House

Left in Commerce and Energy

Feb 16, 2023

House

Subcommittee recommends laying on the table (4-Y 2-N)

Feb 13, 2023

House

Assigned sub: Special Subcommittee #5

Feb 08, 2023

House

Referred to Committee on Commerce and Energy

House

Read first time

House

Placed on Calendar

Feb 03, 2023

Senate

Reconsideration of passage agreed to by Senate (38-Y 0-N)

Senate

Impact statement from DPB (SB957E)

Senate

Passed Senate (26-Y 13-N)

Senate

Read third time and passed Senate (25-Y 14-N)

Feb 02, 2023

Senate

Engrossed by Senate as amended SB957E

Senate

Read second time

Senate

Reading of amendments waived

Senate

Committee amendments agreed to

Senate

Printed as engrossed 23100215D-E

Feb 01, 2023

Senate

Constitutional reading dispensed (40-Y 0-N)

Jan 31, 2023

Senate

Reported from Finance and Appropriations with amendments (13-Y 2-N)

Senate

Senate committee, floor amendments and substitutes offered

Jan 26, 2023

Senate

Impact statement from DPB (SB957)

Jan 16, 2023

Senate

Reported from Commerce and Labor (11-Y 4-N)

Senate

Rereferred to Finance and Appropriations

Jan 06, 2023

Senate

Referred to Committee on Commerce and Labor

Senate

Introduced bill reprinted 23100215D

Senate

Prefiled and ordered printed; offered 01/11/23 23100215D

Bill Text

Bill Text Versions Format
SB957 PDF HTML
Printed as engrossed 23100215D-E PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.